Thank you very much, Mr. Wilks.
I want to start off by giving Dr. Hoch the opportunity to finish off where we left off last time, because I do find it amazing how we analyze and test the validity of some of these protocols. You can have an old drug, but I think sometimes a new drug doesn't have to be tested against the old drug. They're just tested against placebos. The new drugs sometimes cost 10 times the cost of the old drug. I was just wondering if you could give us some insight on your comment that we should invest in research to determine the value of these things. That's question number one.
The other question was for Dr. Jaffray. You mentioned that you did have a number of patents, commercialization, and I was wondering if you could comment on how you did it? You seem to be one of these guys who's been successful through the system. Do you have any suggestions for the federal government, perhaps recommendations on how we could cut the red tape and have more innovators such as yourself go from an idea through the commercialization, trying to get a patent and getting it out?
So those would be my two questions. I'd better shut up so you have some time to answer them.